retatrutide type 2 diabetes phase 2 trial hba1c Clinical – My Endo Consult Media Centre | EASD

Cornelius Krasel, University of Marburg, Germany Updates Copyright 2021 Lafferty, OHarte, Irwin, Gault and Flatt

These results follow similar findings from the companys ATTAIN-1 trial released earlier this month, which tested the drug on people who were overweight or obese without type 2 diabetes (in general, people without diabetes tend to lose more weight from GLP-1 therapy than those with diabetes)

Retatrutide works by tackling some of the underlying causes of weight gain, not just the symptoms

2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Is Flatter Me PLUS vegan